Randomised Phase II Feasibility Trial of Image-guided External Beam Radiotherapy With or Without High Dose Rate Brachytherapy Boost in Men with Intermediate-risk Prostate Cancer (CCTG PR15/ NCT01982786)

We conducted a multicentre feasibility study to assess the ability to randomise patients between image-guided radiotherapy (IGRT) and IGRT  + high dose rate (HDR) brachytherapy boost and to adhere to appropriate radiation quality assurance standards.

Source: Clinical Oncology - June 11, 2018 Category: Radiology Authors: E. Vigneault, G. Morton, W.R. Parulekar, T.M. Niazi, C.W. Springer, M. Barkati, P. Chung, W. Koll, A. Kamran, M. Monreal, K. Ding, A. Loblaw Tags: Original Article Source Type: research